CME Information
Disclosures
Disclosure Policy
In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commerical Support, the AMA requires that all faculty and planning committee members disclose revelant financial relationships with any commerical or proprietary entity producing health care goods or services relevant the content being planned or presented. The following disclosures are provided:
CME Advisory Board
| Dr. Argoff: | Speaker/Advisory Board: Pfizer, Lilly, Endo Consultant: Pfizer Grant Support: Cephalon, GlaxoSmithKline Speaker’s Bureau: King Pharmaceuticals |
| Dr. Berek: | Nothing relevant to disclose |
| Dr. Chin: | Nothing relevant to disclose |
| Dr. D’Agostino: | Consultant: Pfizer |
| Dr. Ferrell: | Nothing revelant to disclose |
| Dr. Fine: | Advisory Board: Endo, Cephalon, Lilly, Alpharma, Wyeth & GlaxoSmithKline |
| Dr. Fishman: | Consultant: Cephalon, Lilly Consultant, Speaker’s Bureau, Grants/Research Support: Elan, Endo, Janssen, Merck, Pfizer, Purdue |
| Dr. Follett: | Nothing revelant to disclose |
| Dr. Grabois: | Nothing revelant to disclose |
| Dr. Houck: | Nothing revelant to disclose |
| Dr. Hull: | Speakers Bureau: Sanofi Synthelabo |
| Dr. Koman: | Research: Allergan |
| Dr. Kulesz: | Nothing revelant to disclose |
| Dr. Lambing | Nothing revelant to disclose |
| Dr. Lesage: | Nothing revelant to disclose |
| Mr. Lipman: | Speakers Bureau: Pfizer; Merck Consultant: Pfizer, Merck, Bioline Research funding: Medgenex, Progenics |
| Dr. Lippe: | Nothing revelant to disclose |
| Dr. Portenoy: | Consultant: Abbott, Adolor, Alpharma, Anesiva, Archimedes Pharma, Ascent, Aveva, Baxter, Bayer, BioDelivery, Biometrix, Biovail, Cephalon, CombinatoRx, Cytogel, Endo, Fralex, Genentech, GlaxoSmithKline, Globomax, GPC Biotech, Janssen/Ortho-McNeil, Johnson & Johnson, King, Ligand, Merck, Nektar, Neuromed, Novartis, Painceptor, Pfizer, Pharmos, PPD, Sarentis, United Biosource, Xenome, Xenon, Wyeth Research Grants: Alpharma, Cephalon, Endo, GlaxoSmithKline, GW Pharmaceuticals, Organon, Pfizer, Progenics |
| Dr. Savage: | Advisory Board: Reckitt Benckiser, King Pharmaceuticals |
| Dr. Streltzer: | Nothing revelant to disclose |
| Dr. Thompson: | Nothing revelant to disclose |
| Dr. Todd: | Consultant: Johnson & Johnson, Alza |
Independent Reviewer |
|
| Dr. Dickinson: | Nothing revelant to disclose |
AMA Editorial Staff |
|
| Dr. Evans: | Nothing revelant to disclose |
| Ms. Fitzgerald: | Nothing revelant to disclose |
Disclosed financial relationships have been reviewed by the AMA to resolve any potential conflicts of interest. All faculty and planning committee members have attested that their financial relationships do not affect their ability to present well-balanced evidence-based content for this activity.
Disclosure of Off-Label Uses
The content of this CME publication may contain discussion of off-label uses of some of the agents mentioned. Please consult the product prescribing information for full disclosure of labeled uses.
Content provided by: Healthcare Education Products & Standards Group
- Accreditation Statement
- Information
on CME Credit - Instructions
for CME Credit - Financial Support
- Contact Information
- CME Advisory Board
- Disclosures
- CME Needs Assessment
- Intended Audience
- Educational Objectives
- CME Information
- Introduction:
What is Pain? - Pathophysiology of Pain
- Assessing the Patient in Pain
- Evaluation of Pain Characteristics & Intensity
- Summary
- Self-Assessment
- References